Shockwave Medical, Inc. Common Stock
SWAV
SWAV was delisted on the 30th of May, 2024.
90 hedge funds and large institutions have $758M invested in Shockwave Medical, Inc. Common Stock in 2019 Q2 according to their latest regulatory filings, with 55 funds opening new positions, 14 increasing their positions, 11 reducing their positions, and 16 closing their positions.
244% more first-time investments, than exits
New positions opened: 55 | Existing positions closed: 16
78% more capital invested
Capital invested by funds: $427M → $758M (+$331M)
76% more funds holding
Funds holding: 51 → 90 (+39)
27% more repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 11
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$29.9M |
| 2 |
BlackRock
New York
|
+$15.4M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$7.92M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$6.19M |
| 5 |
GGHC
Gilder Gagnon Howe & Co
New York
|
+$5.58M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$11.3M |
| 2 |
RG
Redmile Group
San Francisco,
California
|
-$10M |
| 3 |
Capital World Investors
Los Angeles,
California
|
-$7.28M |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
-$6.69M |
| 5 |
AG
Artal Group
Luxembourg
|
-$5.02M |
SWAV Hedge Fund Activity: Q2 2019 in Review
90 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Shockwave Medical, Inc. Common Stock (SWAV) for Q2 2019, worth a combined $758M — up 78% from $427M a quarter earlier.
Buyers outnumbered sellers: 55 funds opened new SWAV positions and 16 closed out — a net gain of 39 holders — while 14 added to existing stakes and 11 trimmed.
The largest buyer was Vanguard Group, adding an estimated $29.9M. The largest seller was Citadel Advisors, cutting an estimated $11.3M.
- 90 institutional investors held Shockwave Medical, Inc. Common Stock (SWAV) as of Q2 2019, up from 51 in Q1 2019.
- Funds reported $758M of Shockwave Medical, Inc. Common Stock stock for Q2 2019, up 78% quarter-over-quarter.
- 55 funds opened new Shockwave Medical, Inc. Common Stock positions in Q2 2019 and 16 closed out, a net change of +39 holders.
- The largest Shockwave Medical, Inc. Common Stock buyer in Q2 2019 was Vanguard Group, an estimated $29.9M added.
- The largest Shockwave Medical, Inc. Common Stock seller in Q2 2019 was Citadel Advisors, an estimated $11.3M sold.
Based on aggregated 13F filings for Q2 2019.